Antihemophilic factor Interactions
There are 10 drugs known to interact with antihemophilic factor, along with 5 disease interactions. Of the total drug interactions, 1 is major, and 9 are moderate.
Medications known to interact with antihemophilic factor
Note: Showing generic names only.
Antihemophilic factor disease interactions
There are 5 disease interactions with antihemophilic factor which include:
- cardiovascular complications
- inhibitory antibodies
- blood isoagglutinin
- immunodeficiency
- thromboembolic events
Report options
More about antihemophilic factor
- antihemophilic factor consumer information
- Compare alternatives
- Reviews (5)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Lysteda
Lysteda (tranexamic acid) is used to treat heavy menstrual bleeding. Includes Lysteda side effects ...
Hemlibra
Hemlibra is a monoclonal antibody that functions in place of a natural blood-clotting factor that ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
DDAVP
DDAVP is used for diabetes insipidus, hemophilia a, primary nocturnal enuresis, von Willebrand Disease
Qfitlia
Qfitlia is used for hemophilia a, hemophilia a with inhibitors, hemophilia b, hemophilia b with ...
Altuviiio
Altuviiio is a once-weekly recombinant fact VIII replacement therapy used by hemophilia A patients ...
Cyklokapron
Cyklokapron is used for bleeding disorder, factor ix deficiency, hemophilia a
Hympavzi
Hympavzi (marstacimab-hncq) may be used to prevent or reduce the frequency of bleeding episodes ...
Emicizumab
Emicizumab is used for hemophilia a, hemophilia a with inhibitors
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
